Responsive image

Common name


4-methoxy-N-phenyl-benzamide

IUPAC name


4-methoxy-N-phenyl-benzamide

SMILES


c1(ccc(cc1)OC)C(=O)Nc2ccccc2

Common name


4-methoxy-N-phenyl-benzamide

IUPAC name


4-methoxy-N-phenyl-benzamide

SMILES


c1(ccc(cc1)OC)C(=O)Nc2ccccc2

INCHI


InChI=1S/C14H13NO2/c1-17-13-9-7-11(8-10-13)14(16)15-12-5-3-2-4-6-12/h2-10H,1H3,(H,15,16)

FORMULA


C14H13NO2

Responsive image

Common name


4-methoxy-N-phenyl-benzamide

IUPAC name


4-methoxy-N-phenyl-benzamide





Molecular weight


227.259

clogP


2.618

clogS


-3.688

Frequency


0.0003





HBond Acceptor


2

HBond Donor


1

Total Polar
Surface Area


38.33

Number of Rings


2

Rotatable Bond


3

Drug ID Common name Structure CAS Compound class Therapeutic area
FDBD01073 Encainide Responsive image Anti-Arrhythmia Agents; Voltage-Gated Sodium Channel Blockers; Sodium Channel Blockers; Cardiovascular System; Antiarrhythmics, Class I and Iii; Cardiac Therapy; Antiarrythmics, Class I and Iii; Antiarrhythmics, Class Ic; CYP2D6 Inducers; CYP2D6 Inducers (strong); Encainide is a class Ic antiarrhythmic agent which was used for management of irregular heartbeats, such as atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation.
1 , 1
FRAGNAME PDBID SIMILIRITY XSCORE SMILE HAC
4jvq_ligand_3_51.mol2 4jvq 1 -7.37 c1(ccc(cc1)OC)C(=O)Nc1ccccc1 17
4jmu_ligand_3_51.mol2 4jmu 1 -7.04 O(C)c1ccc(C(=O)Nc2ccccc2)cc1 17
4jvq_ligand_4_60.mol2 4jvq 0.96875 -7.30 O(C)c1ccc(cc1)C(=O)Nc1ccc(O)cc1 18
4jmu_ligand_4_60.mol2 4jmu 0.96875 -7.17 O(C)c1ccc(C(=O)Nc2ccc(O)cc2)cc1 18
3fi2_ligand_3_66.mol2 3fi2 0.892308 -7.35 c1cc(ccc1)C(=O)Nc1ccc(OC)cc1 17
3fi3_ligand_3_9.mol2 3fi3 0.892308 -7.28 C(=O)(Nc1ccc(cc1)OC)c1ccccc1 17
4i9i_ligand_3_34.mol2 4i9i 0.84058 -8.15 O(C)c1c(cccc1)NC(=O)c1ccccc1 17
4umq_ligand_4_111.mol2 4umq 0.84058 -8.09 COc1c(C(=O)Nc2ccccc2)cccc1 17
4d2t_ligand_4_32.mol2 4d2t 0.84058 -8.03 c1(ccccc1)NC(=O)c1c(cccc1)OC 17
3fi2_ligand_3_65.mol2 3fi2 0.84058 -7.38 c1cc(ccc1)C(=O)Nc1cccc(OC)c1 17
106 , 11